Literature DB >> 28235230

[Acute Kidney Injury].

Silke Brix, Rolf Stahl.   

Abstract

Acute kidney injury (AKI) is an important part of renal diseases and a common clinical problem. AKI is an acute decline in renal function. Due to a lack of therapeutic options, prevention and optimal management of patients with AKI are the most important strategies. Although seldom the sole cause of patients' death, AKI is associated with a significant increase in mortality. Our objective is to draw the attention towards the prevention of AKI of non-renal causes. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28235230     DOI: 10.1055/s-0042-120174

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Formononetin protects against cisplatin‑induced acute kidney injury through activation of the PPARα/Nrf2/HO‑1/NQO1 pathway.

Authors:  Yan Hao; Jie Miao; Wenjia Liu; Li Peng; Yue Chen; Qing Zhong
Journal:  Int J Mol Med       Date:  2020-12-01       Impact factor: 4.101

Review 2.  Emodin-Mediated Treatment of Acute Kidney Injury.

Authors:  Yu Liu; Mingquan Li; LaiKuan Teh; Liangbin Zhao; Naijing Ye; Ling Wu; Lihua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.